DSIP (Delta Sleep Inducing Peptide) 5mg

2025-10-02T15:02:26+03:00

Price: 39.00

What is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide, first discovered in mammalian brain tissue in the 1970s. It is an octapeptide that has been studied in scientific literature for its role in sleep regulation, stress response, and neuroendocrine balance. In research settings, DSIP has been investigated as a modulator of homeostatic processes related to sleep, cortisol levels, and adaptation to psychophysiological stress.

In preclinical and clinical studies, DSIP has been of interest for its potential to promote deep (slow-wave) sleep, stabilize circadian rhythms, and reduce excessive cortisol secretion. Some studies also consider DSIP as a co-regulator of other neurohormones – somatotropin, prolactin, and ACTH – in the body's adaptation to exertion, overwork, and chronic stress.

Observations on DSIP

In scientific literature, DSIP has been studied for its possible role in:

Improving sleep quality – promoting deep sleep and stabilizing circadian rhythms

Regulating cortisol levels – potential effect on stress response and homeostasis

Supporting neuroendocrine function – balancing the secretion of hormones involved in sleep and adaptation

Neuroprotection – potential antioxidant and anti-stress effect on the central nervous system

Stimulating restorative processes – studied in cases of physical and mental overexertion

Mood modulation – some studies discuss its involvement in serotonergic regulation

Administration and Dosage

In scientific literature, subcutaneous administration of 100-300 μg daily, usually in the evening before sleep, has been described. It is used for studying neuroendocrine mechanisms, without an approved therapeutic dose.

For 5 mg + 3 ml bacteriostatic water:

Concentration = 1.67 mg/ml → 0.06 ml = 100 μg

Example values:

0.06 ml = 100 μg

0.12 ml = 200 μg

0.18 ml = 300 μg

0.24 ml = 400 μg

0.3 ml = 500 μg

Scientific Data

DSIP has been studied in various fields - neuroscience, psychoneuroendocrinology, sports physiology, and gerontology.

In sleep studies, an increase in deep phases (NREM) and better sleep quality have been observed

In stress and fatigue models, a reduction in cortisol and an improvement in recovery indicators have been reported

In chronic exertion, DSIP has been studied for its effect on neuroendocrine balance and adaptation

In neurology, its potential neuroprotective function against oxidative stress is considered

In sports medicine, it is analyzed as a factor for faster recovery in cases of insufficient sleep

Application in Sports and Research Settings

DSIP is not intended for use in sports, but in scientific literature, it is considered for its potential role in adaptation to exertion and sleep regulation in actively training individuals. Due to its possible influence on cortisol and recovery, DSIP is included in the list of peptides subject to control by WADA for professional athletes.

May help normalize sleep during intense training regimens

Is being investigated as a possible factor for better adaptation to chronic fatigue

Potential synergy with peptides regulating the GH/IGF-1 axis

Possible Side Effects

In scientific literature, DSIP is generally well-tolerated. Reported reactions are rare and dose-dependent:

Transient drowsiness or fatigue after administration

Mild dizziness or drop in blood pressure

Headache, hot flashes, or a feeling of relaxation

At higher doses, isolated cases of mild hypotension and reduced concentration are observed due to its sedative effect.

The information is based on published scientific sources and is entirely for educational purposes. It is not intended for the diagnosis, treatment, or prevention of diseases.